Literature DB >> 8143878

Identification of the 23 kDa subunit of tau protein kinase II as a putative activator of cdk5 in bovine brain.

K Ishiguro1, S Kobayashi, A Omori, M Takamatsu, S Yonekura, K Anzai, K Imahori, T Uchida.   

Abstract

Tau protein kinase II (TPKII) was reported previously to be composed of a neuron-rich cdc2-related kinase (PSSALRE/cdk5) and 23 kDa subunit. Here we show that the 23 kDa subunit is a putative activator for the kinase activity. Amino acid sequence analysis revealed that the protein was novel and included a partial similarity of amino acids to a cyclin box important for the interaction with cdc2-related kinase. These results suggest that the 23 kDa subunit, but not cyclin, activates cdk5 in neuronal cells, which no longer exhibit cell cycling but are terminally differentiated cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8143878     DOI: 10.1016/0014-5793(94)80501-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  25 in total

1.  Role of cyclins in neuronal differentiation of immortalized hippocampal cells.

Authors:  W Xiong; R Pestell; M R Rosner
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

Review 2.  Tau as a therapeutic target for Alzheimer's disease.

Authors:  A Boutajangout; E M Sigurdsson; P K Krishnamurthy
Journal:  Curr Alzheimer Res       Date:  2011-09       Impact factor: 3.498

3.  Structure-activity relationship study of 2,4-diaminothiazoles as Cdk5/p25 kinase inhibitors.

Authors:  Joydev K Laha; Xuemei Zhang; Lixin Qiao; Min Liu; Snigdha Chatterjee; Shaughnessy Robinson; Kenneth S Kosik; Gregory D Cuny
Journal:  Bioorg Med Chem Lett       Date:  2011-02-03       Impact factor: 2.823

Review 4.  Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration.

Authors:  M L Billingsley; R L Kincaid
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

Review 5.  Cyclins and cyclin-dependent kinases: a biochemical view.

Authors:  J Pines
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

6.  Inhibition of neuronal cyclin-dependent kinase-5 by staurosporine and purine analogs is independent of activation by Munc-18.

Authors:  K T Shetty; N Amin; P Grant; R W Albers; H C Pant
Journal:  Neurochem Res       Date:  1996-05       Impact factor: 3.996

7.  The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons.

Authors:  M H Lee; M Nikolic; C A Baptista; E Lai; L H Tsai; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

8.  PKA modulates GSK-3beta- and cdk5-catalyzed phosphorylation of tau in site- and kinase-specific manners.

Authors:  Fei Liu; Zhihou Liang; Jianhua Shi; Dongmei Yin; Ezzat El-Akkad; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong
Journal:  FEBS Lett       Date:  2006-10-24       Impact factor: 4.124

9.  Cdk5 regulates the organization of Nestin and its association with p35.

Authors:  Cecilia M Sahlgren; Andrey Mikhailov; Samuli Vaittinen; Hanna-Mari Pallari; Hannu Kalimo; Harish C Pant; John E Eriksson
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

10.  p10, the N-terminal domain of p35, protects against CDK5/p25-induced neurotoxicity.

Authors:  Lingyan Zhang; Wen Liu; Karen K Szumlinski; John Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.